- Information for Patients
- Information for Physicians
- Rosacea Review Newsletter
- Research Grants Program
- Classification of Rosacea
- Grading of Rosacea
- Management Options For Rosacea
- Glossary
- Join Us
- How to Donate
- Press Room
- Links
- Home
Archives
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
- August 2007
- July 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- October 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- February 2006
- January 2006
Links
New Subset for Rosacea?
Monday, October 24, 2011
Individuals with prominent neurologic symptoms might be considered a subset of rosacea, according to a report by Dr. Tiffany Scharschmidt and colleagues at the department of dermatology, University of California-San Francisco.1
In their study of 14 rosacea patients, the researchers found that a high percentage had neurologic (43 percent) or neuropsychiatric (50 percent) conditions such as headache, depression, essential tremor and obsessive-compulsive disorder.
Rosacea is likely to have many causes, they explained, such as contributions from dysfunction of blood vessels as well as the innate immune system – the body’s own self-defense. Based on their clinical findings, they proposed that improper functioning in the nervous system may be comparably important in developing the symptoms of rosacea, and that the role of the nervous system may be a significant consideration for the optimal treatment of this disorder. Nerve dysregulation may contribute to rosacea via various mechanisms, they said, including the release of inflammatory chemical substances, vascular instability and nerve injury leading to symptoms of burning and stinging.
While these early findings are intriguing, this is a small sample size and points to the need for further study. They suggested that further research is needed to better define the underlying pathophysiologic characteristics and to identify additional effective treatment methods.
Reference:
1. Scharschmidt TC, Yost JM, Truong SV, et al. Neurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment. Arch Dermatol 2011;147:123-126.
